Last February, CVS Caremark Corp. announced it would end the sale of tobacco products by Oct. 1, becoming the first national pharmacy chain to do so. The company noted their decision would result in a $2 billion loss in revenue, including $1.5 billion in direct tobacco sales and $500,000 in related purchases. But the company decided that selling tobacco was not in keeping with its broad mission of providing health services and advancing innovation. This week, CVS, which also announced it will change its name to CVS Health, announced it will pull tobacco products from it's shelves almost a month earlier than planned. We applaud CVS for taking this important step forward in reducing access to these deadly products, and we applaud their courage to put public health above profits.
American Heart Association CEO Nancy Brown issued the following statement on the decision by CVS Caremark to phase out tobacco sales:
“Smoking is the No. 1 cause of death in the U.S., killing 443,000 Americans and costing the nation $193 billion in healthcare expenses and lost productivity each year, according to a Surgeon General’s report released last month.
Today’s decision by CVS Caremark is an important step forward in reducing access to these deadly products, and we applaud their courage to put public health above profits. We recognize that $2 billion in tobacco sales represents a significant sum for CVS Caremark, and that makes this decision even more admirable.
First use of cigarettes occurs by 18 years of age 87% of the time, and nearly all (98%) of first use is by 26 years of age. There is no such thing as a ‘casual smoker’, as nicotine begins to addict immediately, and therefore removing the visibility and the availability of tobacco products from major retailers in an important step in preventing youth from ever having that first tobacco product. Tobacco displays have a tremendous impact on our youth, with a direct corollary between exposure to tobacco marketing in stores and smoking initiation. 5.6 million young Americans who are alive today will die from smoking – unless there are more actions like this one today.
Many of our public health partners have joined us in our call for pharmacies to stop selling tobacco products, including the American Medical Association, the American Cancer Society and the American Lung Association. In fact, in 2010, the American Pharmacists Association urged pharmacies to stop selling tobacco and pushed state pharmacy boards to discontinue issuing and renewing licenses of pharmacies that sell these products.
The timing of the announcement today comes just weeks after the 50th anniversary of the historic first Surgeon General’s Report, which concluded that cigarette smoking causes lung cancer. Since that 1964 report, evidence has linked smoking to diseases of nearly all the body’s organs.
Tobacco use persists as the leading preventable cause of heart disease and stroke in our country. Indications of heart disease such as atherosclerosis, hypertension, increased tendency for blood clots, decrease of HDL (good) cholesterol as well as a decreased tolerance for exercise are all directly tied to tobacco use. Inhaling cigarette smoke produces several effects that damage the cerebrovascular system, leading to stroke. In fact, the most recent Surgeon General’s report established more new links, including one between exposure to second-hand smoke and a 20 to 30 percent increased risk for stroke.
On the 50th anniversary of the first Surgeon General’s report, the American Heart Association stood alongside many public health partners in Washington, DC, and called for a new national commitment to end the tobacco epidemic for good. We called for bold action to achieve three goals: 1) Reduce smoking rates, currently at about 18 percent, to less than 10 percent within 10 years; 2) protect all Americans from secondhand smoke within five years; and 3) ultimately eliminate the death and disease caused by tobacco. Today’s action by CVS Caremark represents a positive step forward for this vision.
We call upon other tobacco retailers, in particular pharmacies that play a role in protecting the health of Americans, to follow the excellent example being set by CVS Caremark, and discontinue the sales of this deadly product.”